Talbird SE, Fulton J, La EM, Miao Z, Brogan A, Lewis S. Characteristics and costs of optimized background therapy for treatment of heavily treatment-experienced adults with multidrug-resistant HIV-1 in the US: a clinical trial analysis. Poster presented at the 22nd Annual International AIDS Conference; July 24, 2018. Amsterdam, The Netherlands.
Norback D, Zock JP, Plana E, Heinrich J, Svanes C, Sunyer J. Lung function decline in relation to mould and dampness in the home: the longitudinal European Community Respiratory Health Survey ECRHS II. Thorax. 2011 May;66(5):396-401.
Pipkin S, Scheer S, Okeigwe I, Schwarcz S, Harris DH, Hessol NA. The effect of HAART and calendar period on Kaposi's sarcoma and non-Hodgkin lymphoma: results of a match between an AIDS and cancer registry. AIDS. 2011 Feb 20;25(4):463-71.
Hessol N, Pipkin S, Scheer S, Okeigwe I, Schwarcz S, Harris DH. The effect of HAART and calendar period on Kaposi's sarcoma and non-Hodgkin lymphoma survival time. Poster presented at the 18th Annual Conference on Retroviruses and Opportunistic Infections; 2011.
Kauf TL, Farkouh RA, Earnshaw SR, Watson ME, Maroudas P, Chambers MG. Economic efficiency of genetic screening to inform the use of abacavir sulfate in the treatment of HIV. Pharmacoeconomics. 2010 Nov 1;28(11):1025-39.
Real FG, Svanes C, Omenaas ER, Anto JM, Plana E, Jarvis D. Lung function, respiratory symptoms, and the menopausal transition. J Allergy Clin Immunol. 2008 Jan;121(1):72-80.